Tamoxifen turmoil: new issues emerge as healthy women volunteer to take a potent drug.
D000047:Academies and Institutes; D001943:Breast Neoplasms; D002170:Canada; D032962:Consent Forms; D030881:Disclosure; D064420:Drug-Related Side Effects and Adverse Reactions; D016889:Endometrial Neoplasms; D005260:Female; D006262:Health; D006728:Hormones; D006805:Human Experimentation; D006801:Humans; D007258:Informed Consent; D009026:Mortality; D015337:Multicenter Studies as Topic; D004364:Pharmaceutical Preparations; D010820:Physicians; D010919:Placebos; D011315:Preventive Medicine; D012108:Research Personnel; D035842:Research Subjects; D012306:Risk; D018570:Risk Assessment; D013629:Tamoxifen; D014481:United States; D014838:Volunteers; D014930:Women
Biomedical and Behavioral Research; Hamilton Regional Cancer Centre (ON); National Cancer Institute; National Surgical Adjuvant Breast and Bowel Project